UK markets close in 3 hours 18 minutes

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.8800-0.0300 (-1.03%)
At close: 11:23AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.16B
Enterprise value 6.33B
Trailing P/E 8.14
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.46
Price/book (mrq)0.97
Enterprise value/revenue 0.67
Enterprise value/EBITDA 8.65

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 30.00%
S&P500 52-week change 328.04%
52-week high 32.8800
52-week low 32.8800
50-day moving average 32.8800
200-day moving average 32.8800

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5219.9M
Implied shares outstanding 62.72B
Float 8875.39M
% held by insiders 10.00%
% held by institutions 129.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.75
Trailing annual dividend yield 325.74%
5-year average dividend yield 4N/A
Payout ratio 427.47%
Dividend date 3N/A
Ex-dividend date 414 Jun 2023
Last split factor 210031:10000
Last split date 328 Jan 2014

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.34%
Operating margin (ttm)10.12%

Management effectiveness

Return on assets (ttm)3.82%
Return on equity (ttm)11.63%

Income statement

Revenue (ttm)76.83B
Revenue per share (ttm)47.25
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)N/A
EBITDA 5.29B
Net income avi to common (ttm)4.11B
Diluted EPS (ttm)0.3500
Quarterly earnings growth (yoy)2.60%

Balance sheet

Total cash (mrq)19.76B
Total cash per share (mrq)12.15
Total debt (mrq)13.8B
Total debt/equity (mrq)35.66%
Current ratio (mrq)1.64
Book value per share (mrq)22.68

Cash flow statement

Operating cash flow (ttm)3.8B
Levered free cash flow (ttm)1.64B